Expression-based drug screening of neural progenitor cells from individuals with schizophrenia

Unbiased large scale screening of small molecules for drug discovery in psychiatric disease is technically challenging and financially costly. Here, Readhead and colleagues integrate in silico and in vitro approaches to design and conduct transcriptomic drug screening in schizophrenia patient-derive...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Benjamin Readhead, Brigham J. Hartley, Brian J. Eastwood, David A. Collier, David Evans, Richard Farias, Ching He, Gabriel Hoffman, Pamela Sklar, Joel T. Dudley, Eric E. Schadt, Radoslav Savić, Kristen J. Brennand
Format: article
Langue:EN
Publié: Nature Portfolio 2018
Sujets:
Q
Accès en ligne:https://doaj.org/article/ed2d9e5658de4fa6b0313e02ddefca0f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!